Literature DB >> 3728504

Efficacy of platelet transfusions in immune thrombocytopenia.

J M Carr, M S Kruskall, J A Kaye, S H Robinson.   

Abstract

Records of 11 patients with immune thrombocytopenia (idiopathic and quinidine-induced) were evaluated retrospectively for response to platelet transfusion. Good post-transfusion platelet count increments occurred on one or more occasions in seven of the 11 patients, with 13 of 31 platelet transfusions (42 percent) resulting in immediate post-transfusion increments of 20,000/mm3 or more. Next-day platelet counts remained elevated in association with five of these 13 transfusions. This study demonstrates that, contrary to common opinion, platelet transfusions can raise the platelet count in many patients with immune thrombocytopenia, and therefore may be beneficial in actively bleeding or high-risk patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3728504     DOI: 10.1016/0002-9343(86)90664-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

Review 1.  Pathophysiology and therapeutic options in primary immune thrombocytopenia.

Authors:  Roberto Stasi
Journal:  Blood Transfus       Date:  2010-11-26       Impact factor: 3.443

2.  Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Authors:  Drew Provan; Donald M Arnold; James B Bussel; Beng H Chong; Nichola Cooper; Terry Gernsheimer; Waleed Ghanima; Bertrand Godeau; Tomás José González-López; John Grainger; Ming Hou; Caroline Kruse; Vickie McDonald; Marc Michel; Adrian C Newland; Sue Pavord; Francesco Rodeghiero; Marie Scully; Yoshiaki Tomiyama; Raymond S Wong; Francesco Zaja; David J Kuter
Journal:  Blood Adv       Date:  2019-11-26

3.  Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.

Authors:  Ruchika Goel; Paul M Ness; Clifford M Takemoto; Lakshmanan Krishnamurti; Karen E King; Aaron A R Tobian
Journal:  Blood       Date:  2015-01-14       Impact factor: 22.113

4.  Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum.

Authors:  Charleen Min Li Chan Wah Hak; Yew Oo Tan; Charles Chan
Journal:  BMJ Case Rep       Date:  2012-09-24

5.  Treatment of patients with immune thrombocytopenia admitted to the emergency room.

Authors:  Işıl Bavunoğlu; Ahmet Emre Eşkazan; Muhlis Cem Ar; Mahir Cengiz; Serap Yavuzer; Ayşe Salihoğlu; Şeniz Öngören; Aydın Tunçkale; Teoman Soysal
Journal:  Int J Hematol       Date:  2016-04-29       Impact factor: 2.490

Review 6.  The thrombocytopenic purpuras. Recognition and management.

Authors:  S Gillis
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

7.  Effectiveness of platelet transfusion in dengue Fever: a randomized controlled trial.

Authors:  Muhammad Zaman Khan Assir; Umair Kamran; Hafiz Ijaz Ahmad; Sadia Bashir; Hassan Mansoor; Saad Bin Anees; Javed Akram
Journal:  Transfus Med Hemother       Date:  2013-09-11       Impact factor: 3.747

8.  Long-term management of chronic immune thrombocytopenic purpura in adults.

Authors:  Javier Palau; Isidro Jarque; Miguel A Sanz
Journal:  Int J Gen Med       Date:  2010-10-05

9.  Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.

Authors:  Philip Yi Choi; Eileen Merriman; Ashwini Bennett; Anoop K Enjeti; Chee Wee Tan; Isaac Goncalves; Danny Hsu; Robert Bird
Journal:  Med J Aust       Date:  2021-10-10       Impact factor: 12.776

10.  Thrombocytosis following splenectomy and aortic valve replacement for idiopathic thrombocytopaenic purpura with bicuspid aortic valve.

Authors:  Sarika Katiyar; Payal Kamlesh Ganjsinghani; Rajnish Kumar Jain
Journal:  Indian J Anaesth       Date:  2015-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.